This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: A Vipep Pty Limited. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: David Leong: Innovator in Immuno-Conjugates
Introduction
David Leong is a notable inventor based in Preston, Australia. He has made significant contributions to the field of immunology through his innovative work on immuno-conjugates. His research focuses on the development of proteins that can bind to specific targets, which has important implications for therapeutic applications.
Latest Patents
David Leong holds a patent for "Immuno-conjugates and methods for producing them." This invention provides an isolated protein that includes an immunoglobulin variable region with at least two cysteine residues positioned within framework region 1. The unique arrangement allows for the formation of a disulphide bond between the cysteine residues if they are not conjugated to another compound. The patent also describes a protein that binds to TAG72, along with conjugates of the protein and another compound. This innovation represents a significant advancement in the field of targeted therapies.
Career Highlights
David Leong is associated with A Vipep Pty Limited, where he continues to develop his research and innovations. His work has garnered attention for its potential applications in medical treatments, particularly in cancer therapy.
Collaborations
David has collaborated with notable colleagues, including Peter John Hudson and Paul R. Sanders. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
David Leong is a prominent figure in the field of immunology, with a focus on innovative immuno-conjugates. His contributions through patents and collaborations highlight his commitment to advancing medical science.